Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Monoclonal antibodies for the treatment of multiple sclerosis].
CX3CR1 in multiple sclerosis.
Multiple sclerosis: Evidence for B-cell exchange across the blood-brain barrier.
Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis.
Stress-stimulated volitional coping competencies and depression in multiple sclerosis.
[Characteristics of the autonomous control of cardiac activity in patients with remitting multiple sclerosis.]
[Clinical and epidemiological aspects of multiple sclerosis in the Moscow region.]
Protein Kinase C-theta Inhibitors: A Novel Therapy for Inflammatory Disorders.
Interferon-β-1a-induced psychosis in a patient with multiple sclerosis.
Does helminth activation of toll-like receptors modulate immune response in multiple sclerosis patients?
The Link between CD6 and Autoimmunity: Genetic and Cellular Associations.
Vitamin D receptor biochemical and genetic profiling and HLA-class II genotyping among Lebanese with multiple sclerosis - A pilot study.
Involvement of aquaporin 4 in astrocyte function and neuropsychiatric disorders.
MicroRNA-145 as one negative regulator of astrogliosis.
Lead Candidate (MIS416) Overview
Fingolimod (Gilenya) may improve the chances of conception in women with multiple sclerosis (MS) associated with secondary infertlity.
PEGylated IFNβ-1a in the treatment of multiple sclerosis.
Pathological Involvement of Astrocyte-Derived Lipocalin-2 in the Demyelinating Optic Neuritis.
Clinical outcomes in multiple sclerosis patients following venous angioplasty.
Footfall Placement Variability and Falls in Multiple Sclerosis.
Computer-Assisted Cognitive Rehabilitation of Attention Deficits for Multiple Sclerosis: A Randomized Trial With fMRI Correlates.
Can vitamin d suppress endothelial cells apoptosis in multiple sclerosis patients?
Impaired toll-like receptor 8 signaling in multiple sclerosis.
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
Posttranscriptional Gene Regulation of IL-17 by the RNA-Binding Protein HuR Is Required for Initiation of Experimental Autoimmune Encephalomyelitis.
Pages
« first
‹ previous
…
410
411
412
413
414
415
416
417
418
…
next ›
last »